Jul 17, 2023Fostering a Strategic Partnerships to Penetrate Emerging CBD/THC Research Industry in BoliviaKRTL Holding Group, Inc. (OTC: KRTL), a holding company with two subsidiaries, is pleased to announce that its wholly owned subsidiary KRTL International Corp. (“KRTL”), has entered into a partnership with GIH Life Sciences, LLC, and Industria Quimico Farmaceutica SigmaCorp, LLC in Bolivia and are pleased to announce the signing of a tripartite collaboration agreement. This agreement aims to establish a mutually beneficial relationship that will facilitate the sharing of business practices, general business ventures, and strategic partnership agendas. Together, these industry leaders will leverage their combined expertise to assist in the emerging CBD/THC research industry in Bolivia and explore other strategic opportunities, enabling a mutual competitive advantage.
KRTL Holding Group, Inc. (OTC: KRTL), a holding company with two subsidiaries, is pleased to announce that its wholly owned subsidiary KRTL International Corp. (“KRTL”), has entered into a partnership with GIH Life Sciences, LLC, and Industria Quimico Farmaceutica SigmaCorp, LLC in Bolivia and are pleased to announce the signing of a tripartite collaboration agreement. This agreement aims to establish a mutually beneficial relationship that will facilitate the sharing of business practices, general business ventures, and strategic partnership agendas. Together, these industry leaders will leverage their combined expertise to assist in the emerging CBD/THC research industry in Bolivia and explore other strategic opportunities, enabling a mutual competitive advantage.
KRTL Holding Announces KRTL Biotech Facilitates FDA Registration of SIGMACORP as a U.S. Pharmaceutical Manufacturer
Comments